No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Adding uproleselan to chemotherapy in patients with relapsed or refractory acute myeloid leukemia was well-tolerated with high remission rates

byKathleen Lau

September 30, 2021

in StudyGraphics

RELATED REPORTS

Structured exercise intervention improves survival in colon cancer patients

2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]

AAV gene therapy shows durable benefit in hemophilia B

#VisualAbstract: Addition of pembrolizumab to chemotherapy improves survival in patients with advanced esophageal carcinomas

RelatedReports

Development of a risk index for colorectal cancer screening

Gastroenterology

Structured exercise intervention improves survival in colon cancer patients

July 9, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]

July 8, 2025

Primary thromboembolism prophylaxis may be effective in advanced cancer

Hematology

AAV gene therapy shows durable benefit in hemophilia B

July 7, 2025

Lessons from real-world implementation of lung cancer screening

Oncology

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

July 7, 2025

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

Contact aspiration with stent retrieval no more effective than stent retrieval alone for thrombectomy revascularization in stroke patients

Earlier puberty associated with increased risk of depression in girls

Placebo effect size in treatment-resistant depression in adults

BMW May Have Canceled Its Hybrid Supercar Because of Covid-19

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result